Details for New Drug Application (NDA): 215365
✉ Email this page to a colleague
NDA 215365 describes FLUPHENAZINE DECANOATE, which is a drug marketed by Endo Operations, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, MSN, Mylan Labs Ltd, and Teva Parenteral, and is included in nine NDAs. It is available from eight suppliers. Additional details are available on the FLUPHENAZINE DECANOATE profile page.
The generic ingredient in FLUPHENAZINE DECANOATE is fluphenazine decanoate. There are nineteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the fluphenazine decanoate profile page.
The generic ingredient in FLUPHENAZINE DECANOATE is fluphenazine decanoate. There are nineteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the fluphenazine decanoate profile page.
Summary for 215365
| Tradename: | FLUPHENAZINE DECANOATE |
| Applicant: | Msn |
| Ingredient: | fluphenazine decanoate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 215365
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 215365 | ANDA | Novadoz Pharmaceuticals LLC | 72205-100 | 72205-100-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (72205-100-01) / 5 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 25MG/ML | ||||
| Approval Date: | Nov 2, 2023 | TE: | AO | RLD: | No | ||||
Complete Access Available with Subscription
